Naxpar Pharma is rapidly growing and as we evolve our reach has increased from simply manufacturing to development and marketing of pharmaceutical products across different therapeutic segments in different dosage forms like tablets capsules, liquids, ointments creams and gels. Now, we provide end-to-end solutions, from development to commercialization to market approval.

With it exponentially growing population (upwards of 1.25 billion), India represents a dynamic market and a manufacturing hub. Additionally, the country’s average age of ~29, makes it a hotbed for global companies to enter and leverage this technical manpower for their growth. This huge pool of efficient labour and brainpower can be made available to you at a much lower, cost compared to the rest of the world.

Also keep in mind that in India:

  1. APIs are locally available, decreasing companies’ dependence on imports
  2. Pharma companies have the highest number of USFDA-approved facilities (after the US) for formulations.
Naxpar is keen to explore opportunities with new partners for the following:

  • Setting up of a manufacturing facility in India or abroad
  • Setting up of formulations and development in India or abroad.

We’re keen to collaborate with you! Get in touch so that we can figure out the best way forward.
The information entered below will be forwarded to

Please answer the simple math problem below. This is to prevent automated spam.
  +    =